ZIM
FLNA

Zacks Investment Management’s Filana Therapeutics FLNA Stock Holding History

Zacks Investment Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11,373
Closed -$23K – 591
2018
Q2 		$23K Buy
+11,373
New +$97.5K ﹤0.01% 539
2017
Q1 		– Sell
-29,387
Closed -$117K – 712
2016
Q4 		$117K Buy
+29,387
New +$136K ﹤0.01% 627
2014
Q1 		– Sell
-9,891
Closed -$337K – 765
2013
Q4 		$337K Buy
+9,891
New +$263K 0.01% 514

Other funds holding FLNA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Zacks Investment Management's FLNA Position: Q3 2018 in Review

Zacks Investment Management sold out of Filana Therapeutics (FLNA) in Q3 2018, closing a stake of 11,373 shares — an estimated $23K sold.

Zacks Investment Management first reported a position in FLNA in Q4 2013 and held it in 3 quarters. The position peaked at $337K in Q4 2013. 25 funds tracked by Wall St. Rank hold FLNA as of Q3 2018.

  • Zacks Investment Management reported no remaining Filana Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Zacks Investment Management sold 11,373 Filana Therapeutics shares in Q3 2018, an estimated $23K.
  • Zacks Investment Management first reported a position in Filana Therapeutics in Q4 2013 and held it in 3 quarters.
  • Zacks Investment Management's Filana Therapeutics position peaked at $337K in Q4 2013.
  • 25 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2018.

Based on Zacks Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.